欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
SE/H/0305/001
药品名称
Duagen
活性成分
dutasteride 0.5 mg
剂型
Capsule, soft
上市许可持有人
GlaxoSmithKline (Ireland) Limited
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Portugal (PT)
Italy (IT)
Greece (GR)
许可日期
2002/12/03
最近更新日期
2022/07/19
药物ATC编码
G04CB02 dutasteride
申请类型
TypeLevel1：
New Active Substance
TypeLevel2：
Multiple (Copy) Application
TypeLevel3：
Full Dossier Article 4.8 Di 65/65
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final PL
|
common--combined-clean
Date of last change:2018/10/29
Final SPC
|
common-combined-annotated (1)
Date of last change:2018/10/29
Final SPC
|
common-combined-annotated (5)
Date of last change:2018/10/29
Final SPC
|
common-combined-annotated (3)
Date of last change:2018/10/29
Final SPC
|
common-combined-annotated
Date of last change:2018/10/29
Final SPC
|
common-combined-annotated_2
Date of last change:2018/10/29
Final PL
|
common-combined-clean
Date of last change:2018/10/29
Final SPC
|
common-combined-clean (2)
Date of last change:2018/10/29
Final SPC
|
common-combined-clean (4)
Date of last change:2018/10/29
Final PL
|
common-combined-clean
Date of last change:2018/10/29
Final PL
|
Duodart-combined-clean
Date of last change:2018/10/29
Final PL
|
Duodart-combined-annotated
Date of last change:2018/10/29
Final PL
|
hr-combined-annotated
Date of last change:2018/10/29
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase